Auro Laboratories Ltd share price logo

Auro Laboratories Ltd Share Price

BSE: 530233

Small Cap

Healthcare Sector

₹197.30

+4.00

(+2.07%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Auro Laboratories Ltd Stock Performance

as on November 3, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹193.3
    ₹201.8
    downward going graph

    2.03%

    Downside

    2.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹170
    ₹303
    downward going graph

    13.84%

    Downside

    53.57%

    Upside

    downward going graph

Auro Laboratories Ltd share price movements today

Previous Close
₹193.30
Open
₹197.00
Volume
13.20K
Upper Circuit
₹231.95
Lower Circuit
₹154.65
Day's Low - High
₹193.3 - ₹201.8
52 Week Low - High
₹170 - ₹303

Auro Laboratories Ltd Historical Returns

1 Month Return
-15.26 %
3 Month Return
-27.64 %
1 Year Return
-21.5 %
3 Year Return
+ 147.82 %
5 Year Return
+ 147.82 %

Auro Laboratories Ltd Fundamentals

as on November 3, 2025 at 4:01 pm IST

Market Cap

₹120.47 Cr

Return on Equity (ROE)

4.33

PE Ratio (TTM)

0

Return on capital employed (ROCE)

3.79

Beta (LTM)

0.8

P/B Ratio

3.34

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-114.67

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Auro Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Auro Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Auro Laboratories Ltd image
Auro Laboratories Ltd
NA120.4729.56%0.00119
Quest Laboratories Ltd image
Quest Laboratories Ltd
NA146.09-7.9%0.0013103
Wanbury Ltd image
Wanbury Ltd
NA916.74134.62%0.8830599
Gujarat Themis Biosyn Ltd image
Gujarat Themis Biosyn Ltd
NA5,067.97264.2%0.0048150
Venmax Drugs & Pharmaceuticals Ltd image
Venmax Drugs & Pharmaceuticals Ltd
NA14.6765.11%0.00-1NA
See all

Auro Laboratories Ltd Stock’s Investor Sentiment and Interest

Search interest for Auro Laboratories Ltd Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

Auro Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
15.62
13.52
10.18
13.41
17.98
12.06
5.72
3.1
3.05
7.4
2.77
Other Income
0.43
0.62
0.36
0.32
0.42
0.4
0.2
0.31
0.14
0.13
0.42
Total Income
16.05
14.14
10.55
13.73
18.4
12.46
5.92
3.41
3.2
7.53
3.19
Expenses
15.18
11.17
9.03
10.38
13.9
9.65
4.4
2.38
2.61
6.59
2.74
Operating Profit
0.44
2.35
1.15
3.03
4.08
2.41
1.32
0.72
0.44
0.81
0.03
Operating Profit Margin %
2.82%
17.38%
11.3%
22.6%
22.69%
19.98%
23.08%
23.23%
14.43%
10.95%
1.08%
Profit Before Interest, Tax and Depreciation
0.88
2.97
1.52
3.35
4.5
2.81
1.53
1.03
0.58
0.94
0.45
Interest
0.1
0.13
0.27
0.35
0.44
-0.32
0.25
0.28
0.25
0.3
0.28
Depreciation
0.27
0.3
0.27
0.27
0.27
0.28
0.27
0.27
0.27
0.29
0.27
Profit Before Tax
0.51
2.54
0.98
2.73
3.79
2.85
1.01
0.48
0.06
0.35
-0.1
Tax Paid
0.14
0.75
0.27
0.76
1.05
0.53
0.25
0.12
0.02
-0.04
-
Profit After Tax
0.37
1.78
0.71
1.97
2.73
2.32
0.75
0.36
0.05
0.39
-0.11
Total Net profit including share of profit / Loss from associate company
0.37
1.78
0.71
1.97
2.73
2.32
0.75
0.36
0.05
0.39
-0.11
EPS
0.59
2.86
1.14
3.16
4.39
3.72
1.21
0.57
0.08
0.63
-0.17
Actual EPS
0.59
2.86
1.14
3.16
4.39
3.72
1.21
0.57
0.08
0.63
-0.17
Adjusted EPS
0.59
2.86
1.14
3.16
4.39
3.72
1.21
0.57
0.08
0.63
-0.17
Diluted EPS
0.59
2.86
1.14
3.16
4.39
3.72
1.21
0.57
0.08
0.63
-0.17

Auro Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
35.47
40.79
46.82
43.79
54.25
50.87
52.89
53.64
19.4
Other Income
0.53
0.51
0.96
0.97
0.76
1.09
0.94
1.5
0.66
Total Income
36.01
41.31
47.78
44.76
55.01
51.96
53.84
55.14
20.05
Expenses
31.15
34.56
39.98
37.52
43.01
46.24
48.5
42.97
15.99
Operating Profit
4.32
6.23
6.84
6.27
11.24
4.63
4.39
10.67
3.41
Operating Profit Margin %
12.18%
15.27%
14.61%
14.32%
20.72%
9.1%
8.3%
19.89%
17.58%
Profit Before Interest, Tax and Depreciation
4.86
6.75
7.8
7.24
12
5.72
5.33
12.17
4.06
Interest
1.07
1.09
0.72
0.58
0.46
0.83
0.81
0.74
1.08
Depreciation
0.86
0.93
1.01
1.02
1.04
1.02
1.07
1.09
1.1
Profit Before Tax
2.93
4.73
6.07
5.64
10.5
3.87
3.45
10.34
1.88
Tax Paid
2.11
1.19
1.67
1.58
3.32
1.03
1
2.55
0.04
Profit After Tax
0.82
3.53
4.4
4.05
7.18
2.84
2.44
7.79
1.84
Total Net profit including share of profit / Loss from associate company
0.82
3.53
4.4
4.05
7.18
2.84
2.44
7.79
1.84
EPS
1.31
5.66
7.06
6.51
11.52
4.56
3.92
12.5
2.95
Actual EPS
1.31
5.66
7.06
6.51
11.52
4.56
3.92
12.5
2.95
Adjusted EPS
1.31
5.66
7.06
6.51
11.52
4.56
3.92
12.5
2.95
Diluted EPS
1.31
5.66
7.06
6.51
11.52
4.56
3.92
12.5
2.95

Auro Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
7.88
6.49
6.05
6.87
9.3
12.82
-6.59
3.28
18.81
5.75
Cash Flow from Investing Activities
0.08
-0.58
-1.23
-1.57
-1.54
-3.13
-0.73
-1.01
-3.03
-0.66
Cash Flow from Financing Activities
-5.35
-3.82
-1.77
-1.83
-5.52
-0.46
9.79
-8.17
19.09
17.69
Net Cash Flow
0.09
0.47
1.24
1.86
1.58
8.85
-2.14
-9.98
-0.77
-1.02

Auro Laboratories Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
52.09%
52.09%
52.09%
52.09%
52.09%
52.15%
52.15%
52.15%
52.15%
52.18%
52.18%
52.18%
DII
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
47.9%
47.9%
47.9%
47.9%
47.9%
47.84%
47.84%
47.84%
47.84%
47.82%
47.82%
47.82%
Total Outstanding Shares
62,32,500
62,32,500
62,32,500
62,32,500
62,32,500
62,32,500
62,32,500
62,32,500
62,32,500
62,32,500
62,32,500
62,32,500
Total Shareholders
11,135
10,906
10,501
10,272
9,905
9,441
9,335
9,266
9,265
9,102
8,916
8,860

Auro Laboratories Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Auro Laboratories Ltd.

  • Auro Laboratories Ltd Earnings Results

    Auro Laboratories Ltd’s net profit fell -114.67% since last year same period to ₹0.11Cr in the Q1 2025-2026. On a quarterly growth basis, Auro Laboratories Ltd has generated -128.21% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Auro Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Auro Labs. has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.18% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 14.2% return, outperforming this stock by 35.7%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 47.82% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Auro Labs. stock has moved down by -5.4%

About Auro Laboratories Ltd

Auro Laboratories was founded in 1992 in Mumbai and focuses on manufacturing Active Pharmaceutical Ingredients (API), intermediates and generic formulations that adhere to high standards. It has a primary focus on anti-diabetic drugs, and is introducing more within this segment. It also offers toll and custom manufacturing of APIs and intermediates on a contract basis. Its manufacturing facility is located in Tarapur, India and has an installed capacity of over 500 tonnes/annum. Its presence has been felt in international markets with exports to countries such as the Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom. It has ISO 9001:2000, WHO cGMP and European Directorate of Quality Medicine EDQM certifications.

Revenue: ₹2.77Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.11Cr as on June 2025 (Q1 FY26)
Chairperson Name: Sharat Deorah
OrganisationAuro Laboratories Ltd
IndustryPharmaceuticals
CEOSharat Deorah
E-voting on sharesClick here to vote

FAQs

What is Auro Laboratories Ltd share price today?

Auro Laboratories Ltd share price today stands at ₹197.3 as on at the close of the market. Auro Laboratories Ltd share today touched a day high of ₹201.8 and a low of ₹193.3.

What is the 52 week high and 52 week low range for Auro Laboratories Ltd share?

Auro Laboratories Ltd touched a 52 week high of ₹303 and a 52 week low of ₹170. Auro Laboratories Ltd share price today i.e. is closed at ₹197.3, which is -34.88% down from its 52 week high and 16.06% up from its 52 week low.

What is Auro Laboratories Ltd's market capitalisation today?

Auro Laboratories Ltd market capitalisation is ₹120.47 Cr as on .

How to buy Auro Laboratories Ltd shares?

To buy Auro Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 530233 or Auro Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Auro Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Auro Laboratories Ltd trading volume today?

Auro Laboratories Ltd trading volume is 13.20K as on . This means that 13.20K shares of Auro Laboratories Ltd were bought and sold on the stock market during today's trading session.